However, the stimulatory effect of EGF on TRPM6 activity could be diminished by preincubation of cetuximab, an EGFR blockade, thus affecting Mg2+ transport and leading to hypomagnesemia [45]. The gene discussed is TRPM6; the disease is familial primary hypomagnesemia.